HK1211483A1 - Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntingtons disease - Google Patents
Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntingtons diseaseInfo
- Publication number
- HK1211483A1 HK1211483A1 HK15112315.6A HK15112315A HK1211483A1 HK 1211483 A1 HK1211483 A1 HK 1211483A1 HK 15112315 A HK15112315 A HK 15112315A HK 1211483 A1 HK1211483 A1 HK 1211483A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pridopidine
- rasagiline
- combination
- neurodegenerative disorders
- treating neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706711P | 2012-09-27 | 2012-09-27 | |
| US201361879007P | 2013-09-17 | 2013-09-17 | |
| PCT/US2013/062484 WO2014052935A2 (en) | 2012-09-27 | 2013-09-27 | Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1211483A1 true HK1211483A1 (en) | 2016-05-27 |
Family
ID=50339471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15112315.6A HK1211483A1 (en) | 2012-09-27 | 2015-12-15 | Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntingtons disease |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20150216850A1 (xx) |
| EP (1) | EP2900226A4 (xx) |
| CN (1) | CN104768545A (xx) |
| AU (1) | AU2013323133A1 (xx) |
| BR (1) | BR112015006093A2 (xx) |
| CA (1) | CA2884260A1 (xx) |
| EA (1) | EA201590654A1 (xx) |
| HK (1) | HK1211483A1 (xx) |
| IL (1) | IL237743A0 (xx) |
| MX (1) | MX2015003812A (xx) |
| WO (1) | WO2014052935A2 (xx) |
| ZA (1) | ZA201502597B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| RU2470013C2 (ru) * | 2007-04-12 | 2012-12-20 | НСАБ, Филиаль ау НьюроСёрч Свиден АБ, Сверийе | N-оксидные и/или ди-n-оксидные производные стабилизаторов/модуляторов рецепторов дофамина, проявляющие улучшенные профили сердечно-сосудистых побочных эффектов |
| EA201390332A1 (ru) | 2010-09-03 | 2013-08-30 | Ивакс Интернэшнл Гмбх | Дейтерированные аналоги придопидина, применимые в качестве допаминергических стабилизаторов |
| CN103958469B (zh) | 2011-09-07 | 2016-04-20 | 梯瓦制药国际有限责任公司 | 一种新的普利多匹定盐酸盐多晶型形态 |
| UY34503A (es) | 2011-12-08 | 2013-07-31 | Ivax Int Gmbh | ?sal de bromhidrato de pridopidina? |
| US11090297B2 (en) | 2013-06-21 | 2021-08-17 | Prilenia Neurotherapeutics Ltd. | Pridopidine for treating huntington's disease |
| CA2913781C (en) | 2013-06-21 | 2022-05-10 | Teva Pharmaceutical Industries Ltd. | Use of pridopidine for treating huntington's disease |
| TW201613859A (en) | 2014-06-30 | 2016-04-16 | Teva Pharma | Analogs of PRIDOPIDINE, their preparation and use |
| WO2016106142A1 (en) | 2014-12-22 | 2016-06-30 | Teva Pharmaceuticals International Gmbh | L-tartrate salt of pridopidine |
| US11471449B2 (en) | 2015-02-25 | 2022-10-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| US10603311B2 (en) * | 2015-02-25 | 2020-03-31 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| AR105434A1 (es) | 2015-07-22 | 2017-10-04 | Teva Pharmaceuticals Int Gmbh | Proceso para preparar pridopidina |
| CA3015512C (en) | 2016-02-24 | 2024-01-16 | Teva Pharmaceuticals International Gmbh | Treatment of neurodegenerative eye disease using pridopidine |
| WO2018039477A1 (en) | 2016-08-24 | 2018-03-01 | Teva Pharmaceuticals International Gmbh | Use of pridopidine for treating functional decline |
| WO2018136600A1 (en) * | 2017-01-20 | 2018-07-26 | Teva Pharmaceuticals International Gmbh | Use of pridopidine for the treatment of fragile x syndrome |
| CA3072882C (en) | 2017-08-14 | 2023-03-21 | Prilenia Neurotherapeutics Ltd. | Method of treating amyotrophic lateral sclerosis with pridopidine |
| WO2020110128A1 (en) * | 2018-11-29 | 2020-06-04 | Prilenia Neurotherapeutics Ltd. | Combination of pridopidine and an additional therapeutic agent for treating drug induced dyskinesia |
| EA202193190A1 (ru) * | 2019-06-12 | 2022-03-24 | Прилиния Ньюротерапьютикс Лтд. | Композиция, включающая придопидин и его аналог, для лечения болезни гентингтона и ее симптомов |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904724D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| ES2551481T3 (es) * | 2006-02-21 | 2015-11-19 | Teva Pharmaceutical Industries, Ltd. | Uso de rasagilina para el tratamiento de atrofia multisistémica |
| US8969417B2 (en) * | 2008-06-06 | 2015-03-03 | Pharmatwob Ltd. | Pharmaceutical compositions for treatment of Parkinsons disease |
| US20110206782A1 (en) * | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of dopamine receptor |
-
2013
- 2013-09-27 AU AU2013323133A patent/AU2013323133A1/en not_active Abandoned
- 2013-09-27 WO PCT/US2013/062484 patent/WO2014052935A2/en active Application Filing
- 2013-09-27 EP EP13841945.2A patent/EP2900226A4/en not_active Withdrawn
- 2013-09-27 US US14/426,339 patent/US20150216850A1/en not_active Abandoned
- 2013-09-27 EA EA201590654A patent/EA201590654A1/ru unknown
- 2013-09-27 CA CA2884260A patent/CA2884260A1/en not_active Abandoned
- 2013-09-27 US US14/040,579 patent/US20140088145A1/en not_active Abandoned
- 2013-09-27 CN CN201380050232.1A patent/CN104768545A/zh active Pending
- 2013-09-27 BR BR112015006093A patent/BR112015006093A2/pt not_active IP Right Cessation
- 2013-09-27 MX MX2015003812A patent/MX2015003812A/es unknown
-
2015
- 2015-03-15 IL IL237743A patent/IL237743A0/en unknown
- 2015-04-17 ZA ZA2015/02597A patent/ZA201502597B/en unknown
- 2015-12-15 HK HK15112315.6A patent/HK1211483A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2900226A4 (en) | 2016-03-30 |
| AU2013323133A1 (en) | 2015-05-07 |
| EA201590654A1 (ru) | 2015-12-30 |
| MX2015003812A (es) | 2015-07-17 |
| US20150216850A1 (en) | 2015-08-06 |
| US20140088145A1 (en) | 2014-03-27 |
| CA2884260A1 (en) | 2014-04-03 |
| BR112015006093A2 (pt) | 2017-07-04 |
| IL237743A0 (en) | 2015-05-31 |
| WO2014052935A2 (en) | 2014-04-03 |
| EP2900226A2 (en) | 2015-08-05 |
| WO2014052935A3 (en) | 2014-05-15 |
| CN104768545A (zh) | 2015-07-08 |
| ZA201502597B (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211483A1 (en) | Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntingtons disease | |
| HRP20181976T1 (hr) | Postupci za liječenje poremećaja gubitka kose | |
| HK1203566A1 (en) | Methods and compositions for treating huntingtons disease | |
| HK1214553A1 (zh) | 用於治療神經退行性疾病的拉喹莫德和普利多匹定 | |
| HK1210968A1 (en) | Compositions and treatment for eye diseases and disorders | |
| IL239368A0 (en) | Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system | |
| EP2852388A4 (en) | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| ZA201304334B (en) | Methods for diagnosing and treating eye-length related disorders | |
| EP2903619A4 (en) | PHOSPHODIESTERASE INHIBITORS FOR TREATING TASTE AND ODORAT DISORDERS | |
| IL232710B (en) | l-serine preparations, methods and uses for the treatment of neurodegenerative diseases and disorders | |
| HK1215173A1 (zh) | 治療金黃色葡萄球菌相關疾病的方法 | |
| HK1206607A1 (en) | Compounds and methods for treating aberrant adrenocortical cell disorders | |
| HK1215548A1 (zh) | 用於治療神經變性疾病的方法和組合物 | |
| IL233141A0 (en) | Combined treatment of hearing and balance disorders | |
| EP2903605A4 (en) | ANGIOTENSIN FOR THE TREATMENT OF BRAIN STATES | |
| EP2890370A4 (en) | AGENTS USEFUL FOR THE TREATMENT OF OBESITY, DIABETES AND RELATED DISORDERS | |
| EP2814474A4 (en) | METHOD FOR THE TREATMENT AND PREVENTION OF DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
| EP2872166A4 (en) | COMPOSITIONS AND METHODS OF DETECTING, TREATING AND PREVENTING ILLNESSES AND DISORDERS | |
| EP2893014A4 (en) | TRANSPORTABLE ELEMENTS, TDP-43 AND NEURODEGENERATIVE DISEASES | |
| PL2708148T3 (pl) | Sposób liniowy obróbki mięsa | |
| HK1214293A1 (zh) | 反義寡核苷酸和利用其治療細胞增殖性疾病的方法 | |
| IL238363A0 (en) | Methods for treating eye diseases | |
| GB201218671D0 (en) | Anti-fraud process and system |